期刊文献+

复发胶质瘤的影像诊断与放射治疗

Imaging Diagnosis and Radiotherapy Treatment of Recurrent Glioma
下载PDF
导出
摘要 目的探究复发胶质瘤的影像诊断方法,并阐述放射治疗方法对复发胶质瘤的应用效果。方法于本院2016年1月至2018年1月收治的复发胶质瘤患者中,随机选取56例患者作为研究对象,分为常规手术组和放射治疗组。两组患者均行常规彩色超声影像学诊断方法,常规手术组采用常规治疗方法,予以放射治疗组放射治疗方法。结果常规手术组患者的躯体角色评分为(60.33.88±3.67)分,精神健康评分为(65.71±3.25)分,躯体功能评分为(68.94±3.23)分,情绪角色评分为(70.99±7.21)分,总体健康评分为(65.75±3.46)分,放射治疗组患者的躯体角色评分为(87.28±4.23)分,精神健康评分为(86.27±4.57)分,躯体功能评分为(85.55±4.06)分,情绪角色评分为(64.36±3.31)分,总体健康评分为(87.44±4.33)分,且放射治疗组患者的存活率更高,治疗效果更好。结论在采用影像学诊断方法确诊患者的病情后,应将放射治疗方法作为首选,实现对复发胶质瘤的有效治愈。 Objective to explore imaging diagnosis of recurrent glioma, and discuss application effect of radiotherapy on recurrent glioma. Methods choose 56 cases recurrent glioma patients treated in our hospital from January 2016 to January 2018 randomly as study objects, divide them into routine operation group and radiotherapy group. Treat two groups with routine color ultrasound imaging diagnosis method, routine operation group was treated with routine treatment, and radiotherapy group with radiotherapy. Results somatic role scores of routine operation group were(60.33.88±3.67), mental health scores were(65.71±3.25), body function scores were(68.94±3.23), emotional role scores were(70.99±7.21), overall health scores were(65.75±3.46). And somatic role scores of radiotherapy group were(87.28±4.23), mental health scores were(86.27±4.57), body function scores were(85.55±4.06), emotional role scores were(64.36±3.31), and overall health scores were(87.44±4.33). In radiotherapy group, survival rate of was higher, and curative effect was better. Conclusion after diagnosis with imaging diagnosis method, radiotherapy should be the first choice to cure recurrent gliomas effectively.
作者 杨晨 YANG Chen(Medicine School,Xinyang Vocational and Technical College,Xinyang,Henan,46400)
出处 《智慧健康》 2018年第18期3-4,共2页 Smart Healthcare
关键词 复发胶质瘤 影像诊断 放射治疗 Recurrent glioma Imaging diagnosis Radiotherapy
  • 相关文献

参考文献8

二级参考文献95

  • 1彭洪娟,姚其卫,赵斌,于台飞,王光彬.单体素1H-MRS在良恶性胶质瘤鉴别诊断中的价值[J].医学影像学杂志,2010,20(12):1761-1763. 被引量:3
  • 2印弘,张艰,高元桂,马林.MRS在脑内占位病变诊断中的应用[J].实用放射学杂志,2007,23(6):721-724. 被引量:6
  • 3Dolecek TA, Propp JM, Stroup NE, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol, 2012, 15(5): 646-647.
  • 4Stupp R, Mason WP, van den Bent M J, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 2005, 352(10): 987-996.
  • 5Negendank W, Sauter R. 1ntratumoral lipids in tI--/MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. Anticaneer Res, 1996, 16(3B): 1533-1538.
  • 6A1-Okaili RN, Krejza J, Woo JH, et al. Intraaxial brain masses: MR imaging-based diagnostic strategy: initial experience. Radiology, 2007, 243(2): 539-550.
  • 7Goebell E, Fiehler J, Ding XQ, et al. Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients-a combined diffusion tensor imaging and H-MR spectroscopy study. AJNR Am J Neuroradiol, 2006, 27(7): 1426-1431.
  • 8Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 2007,114(2): 97-109.
  • 9Cousins JP. Clinical MR spectroscopy: fundamentals, current applications, and future potential. A JR Am J Roentgenol, 1995, 164(6): 1337-1347.
  • 10Bulik M, Jancalek R, Vanicek J, et al. Potential of MR specoseopy for assessment of glioma grading. Clin Neurol Neurosurg, 2013,115(2): 146-153.

共引文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部